|
Aug 5
|
Senzime Secures TetraGraph Installations Across All Sites of World-Leading US Hospital System
|
|
Jul 23
|
Senzime’s TetraGraph System Receives Regulatory Approval in Mexico
|
|
Jul 18
|
Interim Report April-June 2025: 88% Growth in Local Currency
|
|
May 13
|
Senzime Launches Medical Affairs Division and Education Platform to Drive Transformation in Anesthesia Monitoring
|
|
Apr 24
|
Senzime Publishes Annual and Sustainability Report for 2024
|
|
Apr 23
|
Senzime Secures New System-Wide Contract with Major Pacific Northwest US Healthcare System
|
|
Apr 22
|
Interim Report January-March 2025: 94 Percent Growth
|
|
Feb 17
|
Interim report January - December 2024: Our Rapid Growth Journey Continued in 2024 with a 65% Growth Rate
|
|
Oct 15
|
Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 Conference
|
|
Aug 26
|
Interim Report January - June 2024: Strong Sales Growth in US Market
|
|
Aug 26
|
Senzime Provides Market Update and Outlines High Growth Ambitions
|
|
Dec 21
|
Senzime Secures Initial TetraGraph Order from Major New York Metropolitan Region University Hospital Group
|
|
Dec 8
|
Senzime's CEO shares breakthrough patient monitoring technology for safer surgeries
|
|
Nov 30
|
New Number of Shares and Votes in Senzime AB (publ)
|
|
Nov 30
|
Senzime Secures Multiple University Hospital Orders in Germany
|
|
Nov 28
|
Bulletin from Extraordinary General Meeting in Senzime AB (publ)
|
|
Oct 27
|
OTC Markets Group Welcomes Senzime AB to OTCQX
|